Author

Qian Yuan

Massachusetts General Hospital

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1 Assay:multiome· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Aubrey J. Katz· 1 shared Caitlin M. BurkiD· 1 shared Duncan M. MorganiD· 1 shared Elizabeth G. Moseley· 1 shared Emily Liao· 1 shared Evan Alexander ScottiD· 1 shared Jennifer C. Li· 1 shared John Christopher LoveiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Aubrey J. Katz

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GPR15 and CD38 define a subset of peripheral blood pathogenic effector Th2 cells associated with active eosinophilic esophagitis

Caitlin M. Burk, Duncan M. Morgan, Jonathan N. Glickman, Yamini V. Virkud, Emily Liao, Elizabeth G. Moseley, Karina Eva Canziani, Moumita Bhowmik, Jennifer C. Li, Tarun Keswani, Navneet Virk Hundal, Aubrey J. Katz, Qian Yuan, Sarita U. Patil, John Christopher Love, Wayne G. Shreffler

The paper identifies GPR15+ CD38+ peripheral blood Th2 cells associated with active eosinophilic esophagitis, showing potential as a non-invasive biomarker and suggesting new disease mechanisms.

bioRxiv · Nov 16, 2025 · PreprintImmunology

Expression of a RAS degrader via synthetic nanocarrier-mediated mRNA delivery reduces pancreatic tumors

Taylor E. Escher, Simseok A. Yuk, Qian Yuan, Wenan Qiang, Sultan Almunif, Swagat Sharma, Evan Alexander Scott, K.J.F. Satchell

The paper demonstrates that synthetic nanocarriers deliver RAS-degrading mRNA to pancreatic tumors, reducing RAS levels and tumor growth.

ACS Applied Bio Materials · May 29, 2025Peer-reviewedCancer Biology